185 related articles for article (PubMed ID: 28293382)
1. Sarcopenia and non-alcoholic fatty liver disease: Is there a relationship? A systematic review.
Tovo CV; Fernandes SA; Buss C; de Mattos AA
World J Hepatol; 2017 Feb; 9(6):326-332. PubMed ID: 28293382
[TBL] [Abstract][Full Text] [Related]
2. Sarcopenia is an independent risk factor for non-alcoholic steatohepatitis and significant fibrosis.
Koo BK; Kim D; Joo SK; Kim JH; Chang MS; Kim BG; Lee KL; Kim W
J Hepatol; 2017 Jan; 66(1):123-131. PubMed ID: 27599824
[TBL] [Abstract][Full Text] [Related]
3. Impact of Sarcopenia on the Severity of the Liver Damage in Patients With Non-alcoholic Fatty Liver Disease.
Zambon Azevedo V; Silaghi CA; Maurel T; Silaghi H; Ratziu V; Pais R
Front Nutr; 2021; 8():774030. PubMed ID: 35111794
[TBL] [Abstract][Full Text] [Related]
4. Sarcopenia and fatty liver disease.
Kim JA; Choi KM
Hepatol Int; 2019 Nov; 13(6):674-687. PubMed ID: 31705444
[TBL] [Abstract][Full Text] [Related]
5. Sarcopenia is associated with severe liver fibrosis in patients with non-alcoholic fatty liver disease.
Petta S; Ciminnisi S; Di Marco V; Cabibi D; Cammà C; Licata A; Marchesini G; Craxì A
Aliment Pharmacol Ther; 2017 Feb; 45(4):510-518. PubMed ID: 28028821
[TBL] [Abstract][Full Text] [Related]
6. Sarcopenia, sarcopenic obesity and nonalcoholic fatty liver disease.
Polyzos SA; Vachliotis ID; Mantzoros CS
Metabolism; 2023 Oct; 147():155676. PubMed ID: 37544590
[TBL] [Abstract][Full Text] [Related]
7. Sarcopenic obesity in fatty liver.
Merli M; Lattanzi B; Aprile F
Curr Opin Clin Nutr Metab Care; 2019 May; 22(3):185-190. PubMed ID: 30893090
[TBL] [Abstract][Full Text] [Related]
8. Sarcopenic Obesity in Non-Alcoholic Fatty Liver Disease-The Union of Two Culprits.
Emhmed Ali S; Nguyen MH
Life (Basel); 2021 Feb; 11(2):. PubMed ID: 33557355
[TBL] [Abstract][Full Text] [Related]
9. Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults.
Vernon G; Baranova A; Younossi ZM
Aliment Pharmacol Ther; 2011 Aug; 34(3):274-85. PubMed ID: 21623852
[TBL] [Abstract][Full Text] [Related]
10. Sarcopaenia is associated with NAFLD independently of obesity and insulin resistance: Nationwide surveys (KNHANES 2008-2011).
Lee YH; Jung KS; Kim SU; Yoon HJ; Yun YJ; Lee BW; Kang ES; Han KH; Lee HC; Cha BS
J Hepatol; 2015 Aug; 63(2):486-93. PubMed ID: 25772036
[TBL] [Abstract][Full Text] [Related]
11. Sarcopenia is associated with significant liver fibrosis independently of obesity and insulin resistance in nonalcoholic fatty liver disease: Nationwide surveys (KNHANES 2008-2011).
Lee YH; Kim SU; Song K; Park JY; Kim DY; Ahn SH; Lee BW; Kang ES; Cha BS; Han KH
Hepatology; 2016 Mar; 63(3):776-86. PubMed ID: 26638128
[TBL] [Abstract][Full Text] [Related]
12. Relationship between sarcopenia and nonalcoholic fatty liver disease: the Korean Sarcopenic Obesity Study.
Hong HC; Hwang SY; Choi HY; Yoo HJ; Seo JA; Kim SG; Kim NH; Baik SH; Choi DS; Choi KM
Hepatology; 2014 May; 59(5):1772-8. PubMed ID: 23996808
[TBL] [Abstract][Full Text] [Related]
13. Clinical and pathological features of sarcopenia-related indices in patients with non-alcoholic fatty liver disease.
Seko Y; Mizuno N; Okishio S; Takahashi A; Kataoka S; Okuda K; Furuta M; Takemura M; Taketani H; Umemura A; Nishikawa T; Yamaguchi K; Moriguchi M; Itoh Y
Hepatol Res; 2019 Jun; 49(6):627-636. PubMed ID: 30716793
[TBL] [Abstract][Full Text] [Related]
14. Global prevalence, incidence, and outcomes of non-obese or lean non-alcoholic fatty liver disease: a systematic review and meta-analysis.
Ye Q; Zou B; Yeo YH; Li J; Huang DQ; Wu Y; Yang H; Liu C; Kam LY; Tan XXE; Chien N; Trinh S; Henry L; Stave CD; Hosaka T; Cheung RC; Nguyen MH
Lancet Gastroenterol Hepatol; 2020 Aug; 5(8):739-752. PubMed ID: 32413340
[TBL] [Abstract][Full Text] [Related]
15. Nonalcoholic fatty liver disease in the over-60s: Impact of sarcopenia and obesity.
Wijarnpreecha K; Panjawatanan P; Aby E; Ahmed A; Kim D
Maturitas; 2019 Jun; 124():48-54. PubMed ID: 31097179
[TBL] [Abstract][Full Text] [Related]
16. Nonalcoholic steatohepatitis is strongly associated with sarcopenic obesity in patients with cirrhosis undergoing liver transplant evaluation.
Carias S; Castellanos AL; Vilchez V; Nair R; Dela Cruz AC; Watkins J; Barrett T; Trushar P; Esser K; Gedaly R
J Gastroenterol Hepatol; 2016 Mar; 31(3):628-33. PubMed ID: 26399838
[TBL] [Abstract][Full Text] [Related]
17. Prevalence and Predictors of Non-Alcoholic Fatty Liver Disease in Morbidly Obese South Indian Patients Undergoing Bariatric Surgery.
Praveenraj P; Gomes RM; Kumar S; Karthikeyan P; Shankar A; Parthasarathi R; Senthilnathan P; Rajapandian S; Palanivelu C
Obes Surg; 2015 Nov; 25(11):2078-87. PubMed ID: 25835982
[TBL] [Abstract][Full Text] [Related]
18. The Association between Nonalcoholic Fatty Liver Disease and CT-Measured Skeletal Muscle Mass.
Choe EK; Kang HY; Park B; Yang JI; Kim JS
J Clin Med; 2018 Sep; 7(10):. PubMed ID: 30274215
[TBL] [Abstract][Full Text] [Related]
19. Low skeletal muscle mass is associated with non-alcoholic fatty liver disease in Korean adults: the Fifth Korea National Health and Nutrition Examination Survey.
Kim HY; Kim CW; Park CH; Choi JY; Han K; Merchant AT; Park YM
Hepatobiliary Pancreat Dis Int; 2016 Feb; 15(1):39-47. PubMed ID: 26818542
[TBL] [Abstract][Full Text] [Related]
20. A Critical Appraisal of the Definition of Sarcopenia in Patients with Non-Alcoholic Fatty Liver Disease: Pitfall of Adjusted Muscle Mass by Body Weight.
Park H; Jun DW; Park HK; Park KY; Kim M; Hwang HS
Life (Basel); 2020 Sep; 10(10):. PubMed ID: 32977654
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
